HomeNDC LookupRxCUI directory › RxCUI 201848

Vancomycin 125 MG Oral Capsule [Vancocin] — RxCUI 201848

RxNorm drug concept · Semantic branded drug
RxCUI 201848 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI201848
Official nameVancomycin 125 MG Oral Capsule [Vancocin]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asVancocin 125 MG Oral Capsule; Vancocin (as vancomycin hydrochloride) 125 MG Oral Capsule
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)33 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Vancomycin Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • When vancomycin is given by IV, it gets directly into your bloodstream and reaches infections in your blood, heart, bones, lungs, or skin. When it's swallowed, it mostly stays in y...
  • Why am I getting vancomycin by IV instead of taking a pill?
  • The most common thing people notice is flushing, redness, or itching on the face, neck, and upper chest — especially if the infusion runs too fast. This is sometimes called 'Red Ma...
  • What should I watch for during my vancomycin infusion?
📖 Read our full Vancomycin Injection guide →

🕸️ Concept Web — How Vancomycin 125 MG Oral Capsule [Vancocin] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Vancomycin 125 MG Oral Capsule [Vancocin] RxCUI 201848

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Vancomycin 11124
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Vancocin 202368
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Vancomycin Oral Capsule 374281
    • Vancomycin Oral Product 1160501
    • Vancomycin Pill 1160502
    • Vancomycin Oral Capsule [Vancocin] 402421
    • Vancocin Oral Product 1187389
    • Vancocin Pill 1187337
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Vancomycin 125 MG Oral Capsule SCD · 313570
  • Vancomycin 125 MG SCDC · 328783
  • Vancomycin Oral Capsule SCDF · 374281
  • Vancomycin Oral Product SCDG · 1160501
  • Vancomycin Pill SCDG · 1160502

Brand-Name Concepts

  • Vancomycin 125 MG [Vancocin] SBDC · 566030
  • Vancomycin Oral Capsule [Vancocin] SBDF · 402421
  • Vancocin Oral Product SBDG · 1187389
  • Vancocin Pill SBDG · 1187337
  • Vancocin BN · 202368

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 201848 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
62559-0310-20 2 BLISTER PACK in 1 CARTON (62559-310-20) / 10 CAPSULE in 1... Vancocin ANI Pharmaceuticals, Inc. 2014-11-17
62559-0311-20 2 BLISTER PACK in 1 CARTON (62559-311-20) / 10 CAPSULE in 1... Vancocin ANI Pharmaceuticals, Inc. 2014-11-17
Observed labelers: ANI Pharmaceuticals, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.